The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans

Marianna Caterino, Anna Pastore, Maria Grazia Strozziero, Gianna Di Giovamberardino, Esther Imperlini, Emanuela Scolamiero, Laura Ingenito, Sara Boenzi, Ferdinando Ceravolo, Diego Martinelli, Carlo Dionisi-Vici, Margherita Ruoppolo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Methylmalonic acidemia with homocystinuria, cobalamin deficiency type C (cblC) (MMACHC) is the most common inborn error of cobalamin metabolism. Despite a multidrug treatment, the long-term follow-up of early-onset patients is often unsatisfactory, with progression of neurological and ocular impairment. Here, the in-vivo proteome of control and MMACHC lymphocytes (obtained from patients under standard treatment with OHCbl, betaine, folate and L-carnitine) was quantitatively examined by two dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry. Twenty three proteins were found up-regulated and 38 proteins were down-regulated. Consistent with in vivo studies showing disturbance of glutathione metabolism, a deregulation in proteins involved in cellular detoxification, especially in glutathione metabolism was found. In addition, relevant changes were observed in the expression levels of proteins involved in intracellular trafficking and protein folding, energy metabolism, cytoskeleton organization and assembly. This study demonstrates relevant changes in the proteome profile of circulating lymphocytes isolated from treated cblC patients. Some results confirm previous observations in vivo on fibroblast, thus concluding that some dysregulation is ubiquitous. On the other hand, new findings could be tissue-specific. These observations expand our current understanding of the cblC disease and may ignite new research and therapeutic strategies to treat this disorder.

Original languageEnglish
Pages (from-to)969-979
Number of pages11
JournalJournal of Inherited Metabolic Disease
Volume38
Issue number5
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Proteome
Vitamin B 12
Glutathione
Proteins
Two-Dimensional Difference Gel Electrophoresis
Lymphocytes
Therapeutic Human Experimentation
Inborn Errors Metabolism
Betaine
Carnitine
Protein Folding
Cytoskeleton
Folic Acid
Energy Metabolism
Electrophoresis
Mass Spectrometry
Fibroblasts
Gels
Therapeutics

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

The proteome of cblC defect : in vivo elucidation of altered cellular pathways in humans. / Caterino, Marianna; Pastore, Anna; Strozziero, Maria Grazia; Di Giovamberardino, Gianna; Imperlini, Esther; Scolamiero, Emanuela; Ingenito, Laura; Boenzi, Sara; Ceravolo, Ferdinando; Martinelli, Diego; Dionisi-Vici, Carlo; Ruoppolo, Margherita.

In: Journal of Inherited Metabolic Disease, Vol. 38, No. 5, 01.10.2015, p. 969-979.

Research output: Contribution to journalArticle

Caterino, Marianna ; Pastore, Anna ; Strozziero, Maria Grazia ; Di Giovamberardino, Gianna ; Imperlini, Esther ; Scolamiero, Emanuela ; Ingenito, Laura ; Boenzi, Sara ; Ceravolo, Ferdinando ; Martinelli, Diego ; Dionisi-Vici, Carlo ; Ruoppolo, Margherita. / The proteome of cblC defect : in vivo elucidation of altered cellular pathways in humans. In: Journal of Inherited Metabolic Disease. 2015 ; Vol. 38, No. 5. pp. 969-979.
@article{5df5eb1ad9684ff5938f1f75632d539b,
title = "The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans",
abstract = "Methylmalonic acidemia with homocystinuria, cobalamin deficiency type C (cblC) (MMACHC) is the most common inborn error of cobalamin metabolism. Despite a multidrug treatment, the long-term follow-up of early-onset patients is often unsatisfactory, with progression of neurological and ocular impairment. Here, the in-vivo proteome of control and MMACHC lymphocytes (obtained from patients under standard treatment with OHCbl, betaine, folate and L-carnitine) was quantitatively examined by two dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry. Twenty three proteins were found up-regulated and 38 proteins were down-regulated. Consistent with in vivo studies showing disturbance of glutathione metabolism, a deregulation in proteins involved in cellular detoxification, especially in glutathione metabolism was found. In addition, relevant changes were observed in the expression levels of proteins involved in intracellular trafficking and protein folding, energy metabolism, cytoskeleton organization and assembly. This study demonstrates relevant changes in the proteome profile of circulating lymphocytes isolated from treated cblC patients. Some results confirm previous observations in vivo on fibroblast, thus concluding that some dysregulation is ubiquitous. On the other hand, new findings could be tissue-specific. These observations expand our current understanding of the cblC disease and may ignite new research and therapeutic strategies to treat this disorder.",
author = "Marianna Caterino and Anna Pastore and Strozziero, {Maria Grazia} and {Di Giovamberardino}, Gianna and Esther Imperlini and Emanuela Scolamiero and Laura Ingenito and Sara Boenzi and Ferdinando Ceravolo and Diego Martinelli and Carlo Dionisi-Vici and Margherita Ruoppolo",
year = "2015",
month = "10",
day = "1",
doi = "10.1007/s10545-014-9806-4",
language = "English",
volume = "38",
pages = "969--979",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "5",

}

TY - JOUR

T1 - The proteome of cblC defect

T2 - in vivo elucidation of altered cellular pathways in humans

AU - Caterino, Marianna

AU - Pastore, Anna

AU - Strozziero, Maria Grazia

AU - Di Giovamberardino, Gianna

AU - Imperlini, Esther

AU - Scolamiero, Emanuela

AU - Ingenito, Laura

AU - Boenzi, Sara

AU - Ceravolo, Ferdinando

AU - Martinelli, Diego

AU - Dionisi-Vici, Carlo

AU - Ruoppolo, Margherita

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Methylmalonic acidemia with homocystinuria, cobalamin deficiency type C (cblC) (MMACHC) is the most common inborn error of cobalamin metabolism. Despite a multidrug treatment, the long-term follow-up of early-onset patients is often unsatisfactory, with progression of neurological and ocular impairment. Here, the in-vivo proteome of control and MMACHC lymphocytes (obtained from patients under standard treatment with OHCbl, betaine, folate and L-carnitine) was quantitatively examined by two dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry. Twenty three proteins were found up-regulated and 38 proteins were down-regulated. Consistent with in vivo studies showing disturbance of glutathione metabolism, a deregulation in proteins involved in cellular detoxification, especially in glutathione metabolism was found. In addition, relevant changes were observed in the expression levels of proteins involved in intracellular trafficking and protein folding, energy metabolism, cytoskeleton organization and assembly. This study demonstrates relevant changes in the proteome profile of circulating lymphocytes isolated from treated cblC patients. Some results confirm previous observations in vivo on fibroblast, thus concluding that some dysregulation is ubiquitous. On the other hand, new findings could be tissue-specific. These observations expand our current understanding of the cblC disease and may ignite new research and therapeutic strategies to treat this disorder.

AB - Methylmalonic acidemia with homocystinuria, cobalamin deficiency type C (cblC) (MMACHC) is the most common inborn error of cobalamin metabolism. Despite a multidrug treatment, the long-term follow-up of early-onset patients is often unsatisfactory, with progression of neurological and ocular impairment. Here, the in-vivo proteome of control and MMACHC lymphocytes (obtained from patients under standard treatment with OHCbl, betaine, folate and L-carnitine) was quantitatively examined by two dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry. Twenty three proteins were found up-regulated and 38 proteins were down-regulated. Consistent with in vivo studies showing disturbance of glutathione metabolism, a deregulation in proteins involved in cellular detoxification, especially in glutathione metabolism was found. In addition, relevant changes were observed in the expression levels of proteins involved in intracellular trafficking and protein folding, energy metabolism, cytoskeleton organization and assembly. This study demonstrates relevant changes in the proteome profile of circulating lymphocytes isolated from treated cblC patients. Some results confirm previous observations in vivo on fibroblast, thus concluding that some dysregulation is ubiquitous. On the other hand, new findings could be tissue-specific. These observations expand our current understanding of the cblC disease and may ignite new research and therapeutic strategies to treat this disorder.

UR - http://www.scopus.com/inward/record.url?scp=84940462824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940462824&partnerID=8YFLogxK

U2 - 10.1007/s10545-014-9806-4

DO - 10.1007/s10545-014-9806-4

M3 - Article

C2 - 25585586

AN - SCOPUS:84940462824

VL - 38

SP - 969

EP - 979

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 5

ER -